Trial · NCT03207776
An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
NCT03207776, Not applicable, Completed, Wake Forest University Health Sciences; results first posted 2019-10-14
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD. Trials, record NCT03207776. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03207776
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
- NCT number
- NCT03207776
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 4,832 participants, actual
- Lead sponsor
- Wake Forest University Health Sciences
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Usual Care, COPD Clinical Pathway
- First posted
- 2017-07-05
- Last updated
- 2022-04-22
- Results first posted
- 2019-10-14
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Healthcare Utilization | 60 days | Occurrence of Emergency Department, inpatient, or observation encounters after the initial encounter at accrual |
| Secondary | Quality, Comfort, and Care (QCC) Defined Readmission Rate | 30 days | Readmission to the same facility |
| Secondary | Patient-centric (Protocol Defined) Readmission Rate | 30 days | Readmission to any facility within Carolinas HealthCare System |
| Secondary | 30-day COPD Specific, Acute Care Utilization to Any Hospital Within the System | 30 day |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Healthcare Utilization | 60 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Quality, Comfort, and Care (QCC) Defined Readmission Rate | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Patient-centric (Protocol Defined) Readmission Rate | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | 30-day COPD Specific, Acute Care Utilization to Any Hospital Within the System | 30 day | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Healthcare Utilization | Control | 1080 | Participants | ||
| Healthcare Utilization | Intervention | 920 | Participants | ||
| Quality, Comfort, and Care (QCC) Defined Readmission Rate | Control | 321 | Participants | ||
| Quality, Comfort, and Care (QCC) Defined Readmission Rate | Intervention | 286 | Participants | ||
| Patient-centric (Protocol Defined) Readmission Rate | Control | 753 | Participants | ||
| Patient-centric (Protocol Defined) Readmission Rate | Intervention | 659 | Participants | ||
| 30-day COPD Specific, Acute Care Utilization to Any Hospital Within the System | Control | 240 | Participants | ||
| 30-day COPD Specific, Acute Care Utilization to Any Hospital Within the System | Intervention | 179 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Control | 2,479 | |
| Overall Study | STARTED | Intervention | 2,353 | |
| Overall Study | COMPLETED | Control | 2,479 | |
| Overall Study | COMPLETED | Intervention | 2,353 | |
| Overall Study | NOT COMPLETED | Control | 0 | |
| Overall Study | NOT COMPLETED | Intervention | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Control | 0 | 2,479 |
| Total, all-cause mortality | Intervention | 0 | 2,353 |
| Total, other adverse events | Control | 0 | 2,479 |
| Total, other adverse events | Intervention | 0 | 2,353 |
| Total, serious adverse events | Control | 0 | 2,479 |
| Total, serious adverse events | Intervention | 0 | 2,353 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons6
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intervention vs Control: 30-day COPD Specific, Acute Care Utilization to Any Hospital Within the System | Trial comparisons |
| Intervention vs Control: Quality, Comfort, and Care (QCC) Defined Readmission Rate | Trial comparisons |
| Intervention vs Control: Healthcare Utilization | Trial comparisons |
| Intervention vs Control: Patient-centric (Protocol Defined) Readmission Rate | Trial comparisons |
| Intervention vs Control: deaths from any cause | Trial comparisons |
| Intervention vs Control: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03207776
GET https://conductscience.org/api/trials/v1/NCT03207776/registered